| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &General Counsel | EVP &General Counsel
1 company
Mahon Paul A is an EVP &General Counsel at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $20.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $190.52 | $1,143,144.44 | -5.0% | -1.6% | +5.5% | |
| Sep 16, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $204.08 | $1,224,466.95 | -7.2% | -4.6% | +6.3% | |
| Sep 2, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $210.94 | $1,265,649.79 | -3.8% | -10.9% | +5.0% | |
| Aug 23, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $205.82 | $1,234,901.35 | -5.1% | -3.9% | +9.5% |